Ocular Hypertension: all 659 studies

Page 5 of 7. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).CompletedNCT02622334Phase 1
• Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT02617459Phase 3
• Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCTStatus unknownNCT02585375Phase 4
• Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02571712Phase 4
• Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle GlaucomaCompletedNCT02565173Phase 3
• The Effect of Ocular Massage on the Management of Elevated Intraocular Pressure After Acute Angle ClosureCompletedNCT02539758Not applicable
• 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02531152Phase 1
• Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/mlStatus unknownNCT02471105Phase 4
• Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser TrabeculectomyCompletedNCT02434250Not applicable
• A Phase I Clinical Trial of DARCStatus unknownNCT02394613Phase 1
• Survey of Patients Taking IOP-Lowering Eye DropsCompletedNCT02384772
• Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle GlaucomaStatus unknownNCT02379208
• A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02348476
• Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular HypertensionCompletedNCT02312544Phase 2
• Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion.Status unknownNCT02300818Phase 1/2
• The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular SurfaceWithdrawnNCT02295358
• Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAGTerminatedNCT02231515Not applicable
• Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular HypertensionTerminatedNCT02226094Phase 1/2
• Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With CataractStatus unknownNCT02209961
• Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT02179008Phase 2
• The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion PressureCompletedNCT02165631
• A More Engaging Visual Field Test to Increase Use and Reliability in PediatricsCompletedNCT02157025Not applicable
• Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02136940Phase 2
• A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02129673Phase 1/2
• A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular HypertensionCompletedNCT02102750Phase 1
• A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)CompletedNCT02083289Phase 2
• Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular HypertensionTerminatedNCT02047630Phase 4
• A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle GlaucomaCompletedNCT02014142Phase 2
• A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy SubjectsCompletedNCT02003547Phase 1
• Safety and Efficacy of Liposomal Latanoprost in Ocular HypertensionCompletedNCT01987323Phase 1/2
• An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and MoreCompletedNCT01979913Phase 4
• Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked StudyCompletedNCT01975714Phase 4
• A Study of the VISION5 Product in Patients With Glaucoma or Ocular HypertensionCompletedNCT01943721Phase 1
• The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.WithdrawnNCT01927406Phase 4
• A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01917383Phase 2
• Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by LatanoprostCompletedNCT01896180Phase 2
• IOP Lowering Effect of PLT Versus SLT in Naiv OAG PatientsStatus unknownNCT01886456Not applicable
• Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT01868126Phase 2
• Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect SubjectsCompletedNCT01864642Not applicable
• Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor ImagingTerminatedNCT01864317Phase 2
• A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 DaysCompletedNCT01789736Phase 2
• Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion PressureCompletedNCT01779778
• Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle GlaucomaCompletedNCT01739244Phase 2
• Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01737853
• Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OHWithdrawnNCT01721707Phase 3
• An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop InstillationTerminatedNCT01719809
• A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsCompletedNCT01699464Phase 2
• Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in RussiaWithdrawnNCT01696383Phase 4
• Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle GlaucomaCompletedNCT01693315Phase 2
• Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01687426Phase 1
• Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle GlaucomaCompletedNCT01670266Phase 1
• ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) SubjectsCompletedNCT01668524Phase 2
• 24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionCompletedNCT01655758Phase 4
• A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHTCompletedNCT01654484Phase 1/2
• The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General AnesthesiaStatus unknownNCT01567761
• Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT01528111Phase 1/2
• Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular HypertensionStatus unknownNCT01520116Phase 1/2
• Travacom Post Marketing Surveillance StudyWithdrawnNCT01510132Phase 4
• A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle GlaucomaCompletedNCT01493271Phase 2
• Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment EffectCompletedNCT01491867Not applicable
• A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01481077Phase 2
• A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01481051Phase 2
• AR-12286 Fixed Dose Combination to Lower Elevated Intraocular PressureCompletedNCT01474135Phase 2
• Patient Preference Comparison of AZARGA Versus COSOPT in Patients With GlaucomaCompletedNCT01471158Phase 4
• Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical ProstaglandinesStatus unknownNCT01467440
• Efficacy of Selective Laser Trabeculoplasty in Pseudophakic PatientsStatus unknownNCT01467388
• Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%WithdrawnNCT01452009Phase 3
• Ocular Hypertension And Yoga StudyWithdrawnNCT01446588Not applicable
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or TravoprostCompletedNCT01444040Phase 4
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or TravoprostCompletedNCT01443988Phase 4
• Clinical Evaluation of Safety and Efficacy of Refrigeration Free LatanoprostStatus unknownNCT01430923Not applicable
• Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01410188Phase 1/2
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionCompletedNCT01379144Phase 2
• The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With GlaucomaCompletedNCT01369771Phase 4
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaStatus unknownNCT01361841Not applicable
• 24-hour Efficacy of AR-12286CompletedNCT01330979Phase 2
• AL-54478 Proof of Concept StudyCompletedNCT01318252Phase 2
• Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412CTerminatedNCT01312454Phase 2
• Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant AdministrationsCompletedNCT01306461Phase 3
• AR-12286 in Combination With LatanoprostCompletedNCT01302249Phase 2
• Divided Dose of TRAVATAN®CompletedNCT01298687Phase 2
• Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against MonotherapiesCompletedNCT01292460Phase 3
• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionWithdrawnNCT01284166Phase 3
• Adherence With Fixed Versus Unfixed Glaucoma TherapyCompletedNCT01281020
• Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01279083Phase 1/2
• Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg PositioningCompletedNCT01261871
• Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface DiseaseCompletedNCT01254370Phase 2
• The Effect of Intravenous Magnesium Sulfate on Intraocular Pressure Following Tracheal IntubationCompletedNCT01241175Phase 3
• A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01229982Phase 2
• SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm HgCompletedNCT01227291Phase 1/2
• Central Corneal Thickness With SENSIMED TriggerfishCompletedNCT01210963
• Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United KingdomCompletedNCT01206361
• Safety Study of Latanoprost Slow Release InsertTerminatedNCT01180062Phase 1
• A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01168414Phase 3
• Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)CompletedNCT01162603Phase 4
• Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular HypertensionCompletedNCT01126203Phase 3
• A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01123785Phase 1/2
• Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionCompletedNCT01111890Phase 4
• Bimatoprost Versus Travoprost at Cairo UniversityCompletedNCT01092273
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye DropsCompletedNCT01087671Phase 3

← Ocular Hypertension overview